ask="0.5890"
ask_size="500"
average_daily_volume="3298930"
bid="0.5800"
bid_size="11700"
book_value="0.1680"
change="-0.0095"
change_from_200_day_moving_average="0.2420"
change_from_50_day_moving_average="0.2320"
change_from_52_week_high="-0.0745"
change_From_52_week_low="0.3135"
change_in_percent="-1.5703%"
close="0.5955"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.6220"
high_52_weeks="0.6700"
last_trade_date="3/1/2017"
last_trade_price="0.5955"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="0.5621"
low_52_weeks="0.2820"
market_capitalization="153.13M"
moving_average_200_day="0.3535"
moving_average_50_day="0.3635"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.6187"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+68.4792%"
percent_change_from_50_day_moving_average="+63.8109%"
percent_change_from_52_week_high="-11.1194%"
percent_change_from_52_week_low="+111.1702%"
previous_close="0.6050"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.6012"
price_per_sales="2.8560"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.6200"
stock_exchange="NCM"
symbol="PPHM"
volume="6977823"
weeks_range_52="0.2820 - 0.6700"
